Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept Meera Tarazi, BA, Kumpol Aiempanakit, MD, Victoria P. Werth, MD JAAD Case Reports Volume 4, Issue 7, Pages 698-700 (August 2018) DOI: 10.1016/j.jdcr.2018.03.008 Copyright © 2018 Terms and Conditions
Fig 1 Clinical features of SCLE show erythematous, annular, and scaly plaques on chest. JAAD Case Reports 2018 4, 698-700DOI: (10.1016/j.jdcr.2018.03.008) Copyright © 2018 Terms and Conditions
Fig 2 Clinical improvement of chest 3 months after discontinuation of abatacept and treatment with antimalarials and systemic steroids. JAAD Case Reports 2018 4, 698-700DOI: (10.1016/j.jdcr.2018.03.008) Copyright © 2018 Terms and Conditions